HRTX
Heron TherapeutiNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$162.55M
P/E Ratio
—
EPS
$-0.18
Beta
1.71
52W High
$2.30
52W Low
$0.74
50-Day MA
$0.95
200-Day MA
$1.18
Dividend Yield
—
Profit Margin
-20.50%
Forward P/E
46.95
PEG Ratio
-0.18
About Heron Therapeuti
Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $150.71M |
| Gross Profit (TTM) | $94.65M |
| EBITDA | $-8.16M |
| Operating Margin | -13.70% |
| Return on Equity | -2409.00% |
| Return on Assets | -2.71% |
| Revenue/Share (TTM) | $0.86 |
| Book Value | $0.04 |
| Price-to-Book | 20.10 |
| Price-to-Sales (TTM) | 1.08 |
| EV/Revenue | 1.728 |
| EV/EBITDA | 35.04 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -10.80% |
| Shares Outstanding | $189.28M |
| Float | $135.62M |
| % Insiders | 0.88% |
| % Institutions | 83.29% |
Historical Volatility
HV 10-Day
122.36%
HV 20-Day
98.40%
HV 30-Day
102.82%
HV 60-Day
84.75%
HV Rank
87.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($3.67 target)
1
Strong Buy2
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026